Covered recipient · General Payments record
KATAYOUN Y MOTLAGH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,872.69
- Reported across 369 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $905.89 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $217.67 | 10 |
| Acerta Pharma LLC | $194.97 | 4 |
| AIMMUNE THERAPEUTICS, INC. | $150.99 | 3 |
| Axsome Therapeutics, Inc. | $124.99 | 1 |
| ABBVIE INC. | $82.95 | 3 |
| Lilly USA, LLC | $68.55 | 3 |
| Novo Nordisk AS | $29.26 | 2 |
| Lundbeck LLC | $20.26 | 1 |
| PFIZER INC. | $16.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.09 | 01/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073591 | CMS |
| ABBVIE INC. | $32.10 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073593 | CMS |
| ABBVIE INC. | $28.76 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105073595 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $124.82 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146969223 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $11.41 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146985429 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $14.76 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147008719 | CMS |
| Amgen Inc. | $5.31 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333786 | CMS |
| Amgen Inc. | $5.44 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333788 | CMS |
| Amgen Inc. | $6.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333790 | CMS |
| Amgen Inc. | $8.55 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333792 | CMS |
| Amgen Inc. | $148.46 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656766 | CMS |
| Amgen Inc. | $12.19 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333794 | CMS |
| Amgen Inc. | $9.78 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333796 | CMS |
| Amgen Inc. | $9.39 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333798 | CMS |
| Amgen Inc. | $5.42 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333800 | CMS |
| Amgen Inc. | $6.91 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333802 | CMS |
| AstraZeneca Pharmaceuticals LP | $31.78 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105671937 | CMS |
| AstraZeneca Pharmaceuticals LP | $126.83 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104490454 | CMS |
| AstraZeneca Pharmaceuticals LP | $31.42 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105222243 | CMS |
| AstraZeneca Pharmaceuticals LP | $4.94 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105520821 | CMS |
| Axsome Therapeutics, Inc. | $124.99 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148295230 | CMS |
| Lilly USA, LLC | $33.11 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076471 | CMS |
| Lilly USA, LLC | $13.38 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135099330 | CMS |
| Lilly USA, LLC | $22.06 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135099332 | CMS |
| Lundbeck LLC | $20.26 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145948524 | CMS |
| Novo Nordisk Inc | $15.78 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096603117 | CMS |
| Novo Nordisk Inc | $13.48 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096883576 | CMS |
| PFIZER INC. | $16.25 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131503627 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.